New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma
暂无分享,去创建一个
Akira Matsumura | Tomonori Isobe | Hiraku Kawamura | Izumi Anno | Qiang Yue | Q. Yue | I. Anno | A. Matsumura | T. Isobe | S. Takano | Shingo Takano | Y. Shibata | Yasushi Shibata | Youhei Yamamoto | H. Kawamura | Youhei Yamamoto
[1] O Henriksen,et al. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. , 1993, Magnetic resonance imaging.
[2] J. Peeling,et al. 1H NMR properties of N‐acetylaspartylglutamate in extracts of nervous tissue of the rat , 1992, NMR in biomedicine.
[3] Carles Arús,et al. Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization , 2003, European Radiology.
[4] A R Tate,et al. Magnetic resonance spectroscopy of brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas. , 2001, Journal of neurosurgery.
[5] Mathias Hoehn,et al. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation , 2005, NMR in biomedicine.
[6] B. Miller. A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.
[7] S Cerdán,et al. Nonhistological diagnosis of human cerebral tumors by 1H magnetic resonance spectroscopy and amino acid analysis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] A. Llombart‐Bosch,et al. Histopathological and Cytogenetic Findings in Benign, Atypical and Anaplastic Human Meningiomas: A Study of 60 Tumors , 2000, Journal of Neuro-Oncology.
[9] P. Black,et al. Epidemiology of intracranial meningioma. , 2005, Neurosurgery.
[10] R. Kauppinen,et al. Quantitative Metabolite Patterns of Human Brain Tumors: Detection by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of computer assisted tomography.
[11] G Friedmann,et al. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. , 1992, Radiology.
[12] Hidehiko Kajiwara,et al. Proton Magnetic Resonance Spectroscopy of Brain TumorsAn In Vitro Study , 1994 .
[13] V. L. Doyle,et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.
[14] J. Frahm,et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.
[15] B. Scheithauer,et al. Lipomatous Meningioma: A Clinicopathologic Study of 18 Cases With Special Reference to the Issue of Metaplasia , 2001, The American journal of surgical pathology.
[16] J. Roda,et al. Malignant and atypical meningiomas: a reappraisal of clinical, histological, and computed tomographic features. , 1987, Neurosurgery.
[17] F. Howe,et al. Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS , 2003, Magnetic resonance in medicine.
[18] H. Poptani,et al. Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. , 1995, Magnetic resonance imaging.
[19] H. Mehdorn,et al. MR spectroscopy in patients with intracranial meningiomas , 2007, Neurological research.
[20] J. Hesselink,et al. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas , 2007, Neuroradiology.
[21] R. Gonzalez,et al. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] Y. Kinoshita,et al. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy , 1997, NMR in biomedicine.
[23] J. Sorenson,et al. Localized 2D J-resolved 1H MR spectroscopy: strong coupling effects in vitro and in vivo. , 1995, Magnetic resonance imaging.
[24] C. Arús,et al. Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas , 2003, Neuroradiology.
[25] Gi-Hwan Choi,et al. (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. , 2003, Magnetic resonance imaging.
[26] M. Preul,et al. FLUORESCENT IN SITU HYBRIDIZATION AND EX VIVO 1H MAGNETIC RESONANCE SPECTROSCOPIC EXAMINATIONS OF MENINGIOMA TUMOR TISSUE: IS IT POSSIBLE TO IDENTIFY A CLINICALLY‐AGGRESSIVE SUBSET OF BENIGN MENINGIOMAS? , 2007, Neurosurgery.
[27] J. Hesselink,et al. Malignant meningiomas: CT and histologic criteria, including a new CT sign. , 1982, AJNR. American journal of neuroradiology.
[28] M. Hoehn,et al. 1H‐ and 31P‐MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy‐characteristic profiles of water soluble and lipophilic spectral components , 2001, NMR in biomedicine.
[29] R. Schober,et al. Cystic changes and vascular permeability in meningiomas. , 1988, Clinical neuropathology.
[30] A. Falini,et al. Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives , 1996, Journal of Neurology.
[31] Jimmy D Bell,et al. Approaches to editing, assignment and interpretation of proton spectra , 1991, NMR in biomedicine.
[32] Y. Itai,et al. Chronological change of brain abscess in 1H magnetic resonance spectroscopy , 2002, Neuroradiology.
[33] Stephen Ashwal,et al. Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research , 1998, Pediatric Research.
[34] T R Brown,et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.
[35] S. Morikawa,et al. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. , 1999, Journal of neurosurgery.
[36] A. Dinçer,et al. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. , 2006, European journal of radiology.
[37] J Hennig,et al. Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.
[38] P. Sundgren,et al. Magnetic resonance spectroscopy. , 2005, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[39] M. Castillo,et al. Clinical applications of proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.
[40] M. Hartmann,et al. [Magnetic resonance spectroscopy of brain tumours]. , 2005, Der Nervenarzt.
[41] Y. Kinoshita,et al. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. , 1994, Neurosurgery.